C16 Ganglioside GM3-d9 (d18:1/16:0-d9) (ammonium salt, synthetic)

Formulation: A film

Formal Name: N-[(1S,2R,3E)-1-[[[O-(N-acetyl-α-neuraminosyl)-(2→3)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-hexadecanamide-13,13,14,14,15,15,16,16,16-d9, monosodium salt

Purity: ≥99% deuterated forms (d1-d9); ≤1% d0

Formula Markup: C57H94D9N2O21 • NH4

Formula Weight: 1179,5

Shelf life (days): 730

Notes: C16 Ganglioside GM3-d9 (d18:1/16:0-d9) is intended for use as an internal standard for the quantification of C16 ganglioside GM3 by GC- or LC-MS. C16 Ganglioside GM3 (d18:1/16:0) is a monosialylated ganglioside. It has been found in human fetal frontal lobe tissue isolated in the 27th gestational week but not in human fetal anencephalic residual brain tissue isolated in the 28th gestational week.{53905} C16 Ganglioside GM3 (d18:1/16:0) is higher in the serum of patients with visceral fat accumulation (VFA) and patients with VFA and dyslipidemia compared to healthy lean control subjects.{53906} Serum levels of C16 ganglioside GM3 (d18:1/16:0) are inversely correlated with erythrocyte counts in patients with hematological diseases, including patients with lymphoid neoplasms.{53907}

• Artikelnummer: CAY39225-250
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 39225-250
• Verpackungseinheit: 250 µg
• Mengeneinheit: STK
• Methode: GC-MS, LC-MS, Isotopenmarkierung